The United States metal biliary stent market accounts for the largest share in North America, supported by the country’s high burden of pancreatic cancer, liver disorders, and other hepatobiliary diseases requiring advanced interventional treatment. Increasing demand for minimally invasive procedures, combined with the widespread availability of sophisticated endoscopy centers and highly...